Curated news across firms, funds and deals — updated as our analysts add it.
Jul ’26 was the most active month with 32 tracked items. Update leads this view (14 of 14).
Arcmont was ranked #1 in mid-cap deal volume, joint #1 in large-cap deal count and #2 European Direct Lender for 1H26.
CAA published its H1 2026 consolidated financial statements.
Octus recognized Varde as the leading private credit lender in India during H1 2026. Varde reported more than $13 B invested across APAC.
Freenome announced FDA approval of its blood-based colorectal-cancer screening test.
Fitch affirmed UniCredit at A-, stable outlook, following the Commerzbank offer.
S&P affirmed UniCredit at A- with positive outlook following the Commerzbank offer.
Public reporting indicated strong first-half performance across Lone Pine's long and short positions.
BCPP's Joint Committee reviewed the integration of new Partner Funds and further development of investment management capabilities, including legacy private markets management and capital call services.
ART's High Growth option delivered 10.07% p.a. over the 10 years to 30 June 2026 and 9.21% for FY2026.
AustralianSuper reported that it manages more than A$430 billion for more than 3.6 million members following FY2026 growth.
AustralianSuper reported 9.77% for its Balanced option and 11.58% for High Growth for FY2026. Unlisted assets, led by private credit and private equity, contributed meaningfully to returns.
Coller reported continued institutional commitment to private markets while investors became more selective in manager selection.
Arcmont was recognised in the 2026 European direct-lending awards cycle.
CEO Anthony Fobel discussed private-credit performance and the market outlook amid continued scrutiny of the asset class.